ALUNBRIG 90 MG 28 FILM KAPLI TABLET
Condition : New
0
From UAE
To United States
in 5-10 days
Description
- Mechanism of Action: ALUNBRIG (brigatinib) is a medication used to treat a specific type of lung cancer called ALK-positive metastatic non-small cell lung cancer (NSCLC). It works by inhibiting certain proteins, including ALK (anaplastic lymphoma kinase) and ROS1 (ROS proto-oncogene 1), which are involved in the growth and survival of cancer cells. By blocking these proteins, ALUNBRIG helps to slow down or stop the growth of cancer cells.
- Benefits: The benefits of ALUNBRIG include:
- Treatment of ALK-positive metastatic NSCLC in patients who have progressed on or are intolerant to crizotinib (another medication used to treat ALK-positive NSCLC).
- Delaying disease progression.
- Improving overall survival in certain patient populations.
- Dosage and Administration: ALUNBRIG is taken orally in the form of film-coated tablets. The recommended dosage and administration schedule are determined by a healthcare professional based on factors such as the patient’s weight, medical history, and any previous treatments received. It’s important to follow the prescribed dosage and administration instructions carefully.
- Suitability: ALUNBRIG is indicated for patients with ALK-positive metastatic NSCLC who have progressed on or are intolerant to crizotinib. The suitability of ALUNBRIG for an individual patient would be assessed by a healthcare professional based on factors such as the patient’s medical history, current medications, and overall health status.
- Availability: ALUNBRIG is available by prescription only and can be obtained from pharmacies or medical facilities where oncology medications are dispensed.
- Pricing: Prices of ALUNBRIG can vary between countries and regions. To obtain specific pricing information for ALUNBRIG 90 MG 28 FILM-COATED TABLETS in different countries, you would need to consult pharmaceutical databases, local pharmacies, or healthcare providers in those regions.